← FDA Drug Approvals (Drugs@FDA)
LISDEXAMFETAMINE DIMESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2024-02-02
Drug application
- FDA Application #
ANDA218306- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Active ingredients
- LISDEXAMFETAMINE DIMESYLATE
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MSN
- Manufacturer
- Novadoz Pharmaceuticals LLC
- First approval
- 2024-02-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown